Bayer Aleve Cold & Sinus
This article was originally published in The Tan Sheet
Executive Summary
FDA grants the line extension three years of Hatch/Waxman marketing exclusivity, expiring Nov. 29, 2002. The 220 mg naproxen sodium/120 mg pseudoephedrine hydrochloride combo approved by FDA Nov. 29 has not yet launched (1"The Tan Sheet" Dec. 6, 1999, p. 3)
You may also be interested in...
Aleve Cold & Sinus Bolstered By $19 Mil. Ad Spend
Bayer Consumer Care's Aleve Cold & Sinus - "the only brand that can provide all day relief of pain and nasal congestion with just one pill" - will arrive on food, drug and mass shelves nationwide in August. The launch comes nearly nine months after FDA approval.
Aleve Cold & Sinus Bolstered By $19 Mil. Ad Spend
Bayer Consumer Care's Aleve Cold & Sinus - "the only brand that can provide all day relief of pain and nasal congestion with just one pill" - will arrive on food, drug and mass shelves nationwide in August. The launch comes nearly nine months after FDA approval.
Aleve Cold & Sinus Bolstered By $19 Mil. Ad Spend
Bayer Consumer Care's Aleve Cold & Sinus - "the only brand that can provide all day relief of pain and nasal congestion with just one pill" - will arrive on food, drug and mass shelves nationwide in August. The launch comes nearly nine months after FDA approval.